Category: Article Category

ISPOR PUBLISHES TASK FORCE REPORT #2 ON MULTIPLE CRITERIA DECISION ANALYSIS

Second Report Published in March/April Issue of Value in Health Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report

Posted in Announcements, Brief Report, ISPOR News & Press, Value in Health Tagged with: , , , , , , , , , , , ,

ISPOR PUBLISHES NEW GLOBAL HEALTH CARE SYSTEMS ROAD MAP FOR DENMARK PHARMACEUTICALS

Princeton, NJ—January 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it has published a new Global Health Care Systems Road Map—Denmark Pharmaceuticals. 

Posted in Announcements, Brief Report, ISPOR News & Press Tagged with: , , , , , ,

COST OF DIABETES MELLITUS – IS EARLY DIAGNOSIS A SAVIOR?

Accra, Ghana – The number of diabetes cases and the associated health care budget has been increasing worldwide. It has thus become a growing public health burden for patients, health care providers, and society. The cost of diabetes study has

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , ,

GENERATING EQ-5D-5L HEALTH STATE VALUES IN THE UAE

Abu Dhabi, UAE – Evidence on the health-related quality of life of patients is increasingly being requested by payers in the Middle East. Yet, no EQ-5D-5L value sets are currently available to inform decision making in the region’s health care

Posted in ISPOR News & Press, Preference-Based Assessments, Value in Health Regional Issues Tagged with:

DECONSTRUCTING PHARMACEUTICAL TENDERING: UNDERSTANDING THE UNDERLYING ELEMENTS

Latsia, Cyprus – Tendering is an aggressive pricing and reimbursement tool with proven potency in the pharmaceutical sector.  The pharmaceutical sector is exhibiting high annual sales-increase rates; therefore, the need for optimized, potent, and sustainable pricing and reimbursement tools is

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , , ,